Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (9)

2023

  1. Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

2021

  1. The current role of the heavy/light chain assay in the diagnosis, prognosis and monitoring of multiple myeloma: An evidence-based approach

    Diagnostics, Vol. 11, Núm. 11

2019

  1. GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant

    Stem Cell Research, Vol. 41

2018

  1. Changes in the Management and Prognosis of Ovarian Cancer Due to the New FIGO and WHO Classifications: A Case Series Observational Descriptive Study. Seven Years of Follow-up

    International Journal of Gynecological Cancer, Vol. 28, Núm. 8, pp. 1461-1470

2017

  1. Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial

    Breastfeeding Medicine, Vol. 12, Núm. 4, pp. 202-209

2015

  1. Increased Klk9 urinary excretion is associated to hypertension-induced cardiovascular damage and renal alterations

    Medicine (United States), Vol. 94, Núm. 41

2013

  1. Atrial fibrillation and stroke risk after coronary artery bypass grafting surgery

    Journal of Atrial Fibrillation, Vol. 6, Núm. 3, pp. 23-28

2012

  1. Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer

    Drug Metabolism Reviews, Vol. 44, Núm. 2, pp. 148-172